These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 20131981)
1. Lipid nanoparticles loaded with 10-hydroxycamptothecin-phospholipid complex developed for the treatment of hepatoma in clinical application. Wei W; Shi SJ; Liu J; Sun X; Ren K; Zhao D; Zhang XN; Zhang ZR; Gong T J Drug Target; 2010 Aug; 18(7):557-66. PubMed ID: 20131981 [TBL] [Abstract][Full Text] [Related]
2. Intracellular target delivery of 10-hydroxycamptothecin with solid lipid nanoparticles against multidrug resistance. Liu M; Chen D; Wang C; Chen X; Wen Z; Cao Y; He H J Drug Target; 2015; 23(9):800-5. PubMed ID: 25766079 [TBL] [Abstract][Full Text] [Related]
3. Lipid nanoparticles loaded with 7-ethyl-10-hydroxycamptothecin-phospholipid complex: in vitro and in vivo studies. Liu H; Lu H; Liao L; Zhang X; Gong T; Zhang Z Drug Deliv; 2015; 22(6):701-9. PubMed ID: 24625262 [TBL] [Abstract][Full Text] [Related]
4. Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery. Zu Y; Meng L; Zhao X; Ge Y; Yu X; Zhang Y; Deng Y Int J Nanomedicine; 2013; 8():1207-22. PubMed ID: 23569373 [TBL] [Abstract][Full Text] [Related]
5. Intracellular delivery of 10-hydroxycamptothecin with targeted nanostructured lipid carriers against multidrug resistance. Liu M; Chen D; Mukerabigwi JF; Chen S; Zhang Y; Lei S; Luo S; Wen Z; Cao Y; Huang X; He H J Drug Target; 2016; 24(5):433-40. PubMed ID: 26422582 [TBL] [Abstract][Full Text] [Related]
6. [Preparation of PEG-modified nanostructured lipid carriers loaded with hydroxycamptothecin and tissue distribution in mice]. Zhang XX; Gan Y; Yang XG; Zhu CL; Gan L; Nie SF; Pan WS Yao Xue Xue Bao; 2008 Jan; 43(1):91-6. PubMed ID: 18357740 [TBL] [Abstract][Full Text] [Related]
7. Hydroxycamptothecin-loaded nanoparticles enhance target drug delivery and anticancer effect. Wang A; Li S BMC Biotechnol; 2008 May; 8():46. PubMed ID: 18454874 [TBL] [Abstract][Full Text] [Related]
8. Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles. Yang L; Cui F; Cun D; Tao A; Shi K; Lin W Int J Pharm; 2007 Aug; 340(1-2):163-72. PubMed ID: 17482779 [TBL] [Abstract][Full Text] [Related]
9. PEGylated nanostructured lipid carriers loaded with 10-hydroxycamptothecin: an efficient carrier with enhanced anti-tumour effects against lung cancer. Zhang X; Gan Y; Gan L; Nie S; Pan W J Pharm Pharmacol; 2008 Aug; 60(8):1077-87. PubMed ID: 18644200 [TBL] [Abstract][Full Text] [Related]
10. Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles. Hong M; Zhu S; Jiang Y; Tang G; Sun C; Fang C; Shi B; Pei Y J Control Release; 2010 Jan; 141(1):22-9. PubMed ID: 19735683 [TBL] [Abstract][Full Text] [Related]
11. Sustained release of hydroxycamptothecin after subcutaneous administration using a novel phospholipid complex-DepoFoam technology. Zhao Y; Liu J; Sun X; Zhang ZR; Gong T Drug Dev Ind Pharm; 2010 Jul; 36(7):823-31. PubMed ID: 20515403 [TBL] [Abstract][Full Text] [Related]
12. A stabilizer-free and organic solvent-free method to prepare 10-hydroxycamptothecin nanocrystals: in vitro and in vivo evaluation. Yang X; Liu Y; Zhao Y; Han M; Guo Y; Kuang H; Wang X Int J Nanomedicine; 2016; 11():2979-94. PubMed ID: 27382284 [TBL] [Abstract][Full Text] [Related]
13. Preparation, Characterization, and in vivo Evaluation of NK4-Conjugated Hydroxycamptothecin-Loaded Liposomes. Zhou T; Zhang W; Cheng D; Tang X; Feng J; Wu W Int J Nanomedicine; 2020; 15():2277-2286. PubMed ID: 32280220 [TBL] [Abstract][Full Text] [Related]
14. Glycyrrhetinic Acid and TAT Peptide Modified Dual-functional Liposomes for Treatment of Hepatocellular Cancer. Huang S; Ren D; Wu X; Li M; Yu X; Nie X; Wang Y; Wang Y Curr Top Med Chem; 2020; 20(27):2493-2505. PubMed ID: 32703132 [TBL] [Abstract][Full Text] [Related]
15. A polymeric micelle with an endosomal pH-sensitivity for intracellular delivery and enhanced antitumor efficacy of hydroxycamptothecin. Pu X; Zhao L; Li J; Song R; Wang Y; Yu K; Hou X; Qiao P; Zong L; Chang S Acta Biomater; 2019 Apr; 88():357-369. PubMed ID: 30822554 [TBL] [Abstract][Full Text] [Related]
16. Preparation, characterization, biodistribution and antitumor efficacy of hydroxycamptothecin nanosuspensions. Han M; Liu X; Guo Y; Wang Y; Wang X Int J Pharm; 2013 Oct; 455(1-2):85-92. PubMed ID: 23928147 [TBL] [Abstract][Full Text] [Related]
17. 10-Hydroxycamptothecin (HCPT) nanosuspensions stabilized by mPEG Yang L; Hong J; Di J; Guo Y; Han M; Liu M; Wang X Int J Nanomedicine; 2017; 12():3681-3695. PubMed ID: 28553107 [TBL] [Abstract][Full Text] [Related]
18. Enhanced tumor targeting and antitumor efficacy via hydroxycamptothecin-encapsulated folate-modified N-succinyl-N'-octyl chitosan micelles. Zhu H; Cao J; Cui S; Qian Z; Gu Y J Pharm Sci; 2013 Apr; 102(4):1318-32. PubMed ID: 23400693 [TBL] [Abstract][Full Text] [Related]
19. [Study on liver targeting and sustained release hydroxycamptothecin polybutylcyanoacrylate nanoparticles]. Zhang ZR; Lu W Yao Xue Xue Bao; 1997; 32(3):222-7. PubMed ID: 11327027 [TBL] [Abstract][Full Text] [Related]
20. Hydroxycamptothecin nanoparticles based on poly/oligo (ethylene glycol): Architecture effects of nanocarriers on antitumor efficacy. Guo Y; Wang T; Qiu H; Han M; Dong Z; Wang X; Wang Y Eur J Pharm Biopharm; 2019 Jan; 134():178-184. PubMed ID: 30529294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]